Form 4 Tracker
ACADIA PHARMACEUTICALS INC
ACAD

18 insider filings · Latest: May 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 26, 2026May 27 6:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
5,401$21.18$114.4K24,509(D)

View →

May 4, 2026May 5 6:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,332$21.79$29.0K29,129(D)

View →

May 4, 2026May 5 6:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
3,506$21.79$76.4K66,145(D)

View →

Apr 7, 2026Apr 7 7:57 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
2,709$22.20$60.1K62,836(D)

View →

Apr 7, 2026Apr 7 7:55 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,030$22.20$22.9K27,865(D)

View →

Mar 25, 2026Mar 26 8:00 PMAdams Catherine OwenDirector, Chief Executive Officer
Sale
11,641$21.47$249.9K14,803(D)

View →

Mar 25, 2026Mar 26 8:00 PMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Sale
3,844$21.47$82.5K11,280(D)

View →

Mar 25, 2026Mar 26 8:00 PMElizabeth H.Z. ThompsonEVP, Head of Research & Dev
Sale
3,435$21.47$73.7K3,280(D)

View →

Mar 26, 2026Mar 26 8:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,109$21.65$24.0K26,885(D)

View →

Mar 25, 2026Mar 26 8:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
833$21.47$17.9K25,852(D)

View →

Mar 26, 2026Mar 26 8:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
3,208$21.65$69.5K60,269(D)

View →

Mar 25, 2026Mar 26 8:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
4,177$21.47$89.7K57,299(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 4:32 PMBAKER BROS. ADVISORS LPDirector, 10% Owner
Grant/Award
64,016$21.6632,008(I)

View →

May 29, 2026Jun 1 6:00 PMEdmund HarriganDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMEdmund HarriganDirector
Option Exercise
8,1070(D)

View →

May 29, 2026Jun 1 6:00 PMAdora NduDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMAdora NduDirector
Option Exercise
8,1070(D)

View →

May 29, 2026Jun 1 6:00 PMLaura BregeDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMLaura BregeDirector
Option Exercise
8,1070(D)

View →

May 29, 2026Jun 1 6:00 PMJonathan PooleDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMJonathan PooleDirector
Option Exercise
2,0100(D)

View →

May 29, 2026Jun 1 6:00 PMElizabeth A. GarofaloDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMElizabeth A. GarofaloDirector
Option Exercise
8,1070(D)

View →

May 29, 2026Jun 1 6:00 PMJames M DalyDirector
Grant/Award
25,315$21.669,311(D)

View →

May 29, 2026Jun 1 6:00 PMJames M DalyDirector
Option Exercise
8,1070(D)

View →

May 1, 2026May 5 6:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Option Exercise
2,5962,596(D)

View →

May 1, 2026May 5 6:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,8156,815(D)

View →

Apr 5, 2026Apr 7 7:57 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Option Exercise
5,2760(D)

View →

Apr 5, 2026Apr 7 7:55 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Option Exercise
2,0100(D)

View →

Mar 24, 2026Mar 26 8:00 PMAdams Catherine OwenDirector, Chief Executive Officer
Option Exercise
23,50970,530(D)

View →

Mar 24, 2026Mar 26 8:00 PMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Option Exercise
7,51522,547(D)

View →

Mar 24, 2026Mar 26 8:00 PMElizabeth H.Z. ThompsonEVP, Head of Research & Dev
Option Exercise
6,71520,146(D)

View →

Page 1 of 2

Next →